SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
March 30, 2026
 · 
4 min read
Press Releases
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
March 27, 2026
 · 
5 min read
Press Releases
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
March 27, 2026
 · 
5 min read
Press Releases
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
March 27, 2026
 · 
6 min read
Press Releases
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio
March 26, 2026
 · 
2 min read
Press Releases
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
March 26, 2026
 · 
5 min read
Press Releases
PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches
March 26, 2026
 · 
9 min read
Press Releases
OS Therapies Granted EMA’s Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma
March 25, 2026
 · 
6 min read
Press Releases
Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials
March 25, 2026
 · 
11 min read
Press Releases
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
March 24, 2026
 · 
1 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us